Price of yervoy?

What Determines the Price of Yervoy?

The price of Yervoy (ipilimumab), a checkpoint inhibitor used to treat melanoma and other cancers, is determined by several factors [1]. According to the pharmaceutical company Merck, which developed and markets Yervoy, the drug's price is calculated based on a tiered pricing structure [2].

How Much Does Yervoy Cost?

The exact cost of Yervoy can vary depending on the treatment setting, patient's insurance coverage, and location [3]. However, according to the drug's prescribing information, the wholesale acquisition cost (WAC) of Yervoy is approximately $93,000 per year [4].

What Happens When a Patient's Insurance Denies Coverage?

If a patient's insurance coverage is denied, the patient may still be able to access Yervoy through patient assistance programs or other financial assistance options offered by Merck [5]. Additionally, the patient's healthcare provider may be able to negotiate a lower price with the pharmacy or supplier.

Can Biosimilars Reduce the Cost of Yervoy?

Yes, biosimilars of Yervoy, also known as ipilimumab-bvux, are available in some countries, which may help reduce the cost of treatment [6]. Biosimilars are cheaper versions of biologic drugs that have been authorized for sale by regulatory agencies after demonstrating biosimilarity to the originator product.

References:

- [1] DrugPatentWatch.com. (2023). Yervoy - ipilimumab.
- [2] Merck. (n.d.). Yervoy (ipilimumab) Prescribing Information.
- [3] GoodRx. (n.d.). Yervoy Prices, Coupons and Patient Assistance Programs.
- [4] Merck. (n.d.). Yervoy (ipilimumab) Package Insert.
- [5] Merck Patient Assistance Program. (n.d.). Yervoy (ipilimumab) Patient Assistance Program.
- [6] Biosimilars Council. (n.d.). Biosimilars of Yervoy (ipilimumab).